Company
Funding data: Recent Funding. Each amount links to the announcement it came from.
Tolemy Bio
Tolemy Bio develops AI-driven tools to design, optimize, and control cell culture processes for advanced therapies.
Rounds
| Date | Stage | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| May 12, 2026 | Pre-seed | $1.6M | — | — | European Biotechnology Magazine ↗ |
About
- Website
- tolemy.bio
- X
- @TolemyBio
- Based in
- Cambridge, United Kingdom
Founders
- Alex WardCo-founder & CEO
- Caelan AndersonCo-founder & CTO